reference/2560786

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/2560786

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	205
issn	8756-7938 1520-6033
issueIdentifier	1
pageRange	196-205
publicationName	Biotechnology Progress
startingPage	196
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_70d85cc8ebf0353b5cdb311e06bf000f http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_487baf6554eb36bb22c6138d90a7c50f
bibliographicCitation	Li YQ, Liu YS, Ying XW, Zhou HB, Wang Z, Wu SC, Yan JP, Jing YT, Yang Y. Lentivirus-mediated disintegrin and metalloproteinase 17 RNA interference reversed the acquired resistance to gefitinib in lung adenocarcinoma cells in vitro. Biotechnol Prog. 2018 Jan;34(1):196–205. PMID: 28960861; PMCID: PMC6585635.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_66499d70a486aac45eced23fa5cc4fef http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1de6da8f8d7349b1859ada92e9a44ebe http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f19a032463409097660b9e9027992f30 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_645bd5c7c983695f685c121707d165d3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2997c9613b19d674c0fb7f588d418e35 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_47a5ed16adcb84a9d596ff43060be7ea http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-7379-8151 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9fe256b9bcdba5f9382f85a5138c3d3a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d9838f700e3ce452854c5e9ff9944b2c
date	2017-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC6585635 https://pubmed.ncbi.nlm.nih.gov/28960861 https://doi.org/10.1002/btpr.2564
isPartOf	https://portal.issn.org/resource/ISSN/1520-6033 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1558 https://portal.issn.org/resource/ISSN/8756-7938
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Lentivirus‐mediated disintegrin and metalloproteinase 17 RNA interference reversed the acquired resistance to gefitinib in lung adenocarcinoma cells in vitro
discusses	http://id.nlm.nih.gov/mesh/M0485607 http://id.nlm.nih.gov/mesh/M0593322 http://id.nlm.nih.gov/mesh/M0444984 http://id.nlm.nih.gov/mesh/M0265247 http://id.nlm.nih.gov/mesh/M0500817
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000077156Q000494 http://id.nlm.nih.gov/mesh/D000077192Q000188 http://id.nlm.nih.gov/mesh/D000072198Q000235
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D034622 http://id.nlm.nih.gov/mesh/D000077192Q000235 http://id.nlm.nih.gov/mesh/D015972Q000187 http://id.nlm.nih.gov/mesh/D016086Q000235 http://id.nlm.nih.gov/mesh/D017209Q000187 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D010766 http://id.nlm.nih.gov/mesh/D000077192Q000473 http://id.nlm.nih.gov/mesh/D066246Q000235 http://id.nlm.nih.gov/mesh/D019008Q000235 http://id.nlm.nih.gov/mesh/D049109Q000187 http://id.nlm.nih.gov/mesh/D045744
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6650 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8a65ae2c3e323ad41efdc6b71be9712d http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123631 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b670a15e53aa9bf50d9e355f722f98c5 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fddb60309b0ee16f8cd57b4b90c99e89

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID1956 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID6868

Total number of triples: 58.